Background-In the elderly, mitral regurgitation (MR) is frequent, but surgery risks are considered high. Benefits and indications of MR surgery are uncertain in the elderly. Methods and Results-Baseline characteristics, outcome, and trends for surgical results improvement were analyzed in elderly patients (Ն75 years of age; nϭ284) operated on for MR in 1980 to 1995 compared with younger patients (65 to 74 years of age, nϭ504; and Ͻ65 years of age, nϭ556). Preoperatively, class III to IV symptoms, atrial fibrillation, coronary disease, creatinine, and comorbidity index were more severe in elderly patients (all PϽ0.002). In the long term after surgery, observed survival stratified by age (Ն75, 65 to 74, Ͻ65 years) was lower in elderly than in younger patients (at 5 years, 57Ϯ3%, 73Ϯ2%, and 85Ϯ2%, respectively; PϽ0.001), but ratios of observed to expected survival were similar (83%, 85%, and 88%, respectively 
ging of the US population had led to a marked increase in its elderly segment (Ն75 years) that is expected to quadruple over the next 50 years. 1 Recent epidemiological data show that prevalence of mitral regurgitation (MR) increases with age. 2 Thus, elderly patients with MR in whom surgical correction may be considered represent a frequent and growing management problem for which major uncertainties persist. Indeed, mitral surgery is considered high risk in the elderly, [3] [4] [5] with operative mortality commonly reported between 10% and 20%, 6 -8 higher morbidity 6,9 -11 and mediocre long-term survival. Consequently, in elderly patients with MR, surgery usually is indicated for severe and persistent symptoms of heart failure 12 but may not be performed at all 13 on the basis of this purported poor outcome.
Documenting precisely how age affects long-term outcomes is complex, however. In elderly patients, severe preoperative characteristics, 14 such as advanced symptoms of
Editorial p 258 Clinical Perspective p 272
heart failure, higher frequency of coronary artery disease (CAD), and associated comorbid conditions, may contribute to poor surgical outcome. 15, 16 Furthermore, in judging whether a pessimistic appraisal of mitral surgery in the elderly is adequate, the natural age-mortality link has not been accounted for, so long-term survival relative to life expectancy in each age strata after surgery cannot be appreciated.
Recent improvements in surgical techniques suggest a more optimistic view. Indeed, valve repair, which has considerably improved outcome in the younger population, 17 has not been taken into account in defining risk and indication of mitral surgery in the elderly. Therefore, doubt persists as to how the large population of elderly patients with MR should be managed. Thus, the purposes of the present study were to compare clinical characteristics of elderly and younger populations of patients operated on for MR, to assess long-term survival relative to expected survival in each age strata, and to examine time trends in operative mortality and morbidity. Such data aim at evaluating whether recent results justify a more aggressive approach to MR surgery in the elderly.
Methods
The study was based on our consecutive experience with patients who underwent surgical correction for MR with valve repair or replacement between January 1, 1980, and December 31, 1995, at our institution to allow examination of long-term outcome. Exclusion criteria were associated mitral stenosis, associated aortic or tricuspid valve replacement, previous valve repair or replacement, and associated congenital heart or pericardial disease. No exclusions were based on age, sex, MR origin, CAD, and degree of left ventricular (LV) impairment.
Valve disease was considered degenerative 18, 19 if it was due to primary floppy valves, flail leaflets, and/or calcified mitral annulus. Clinical characteristics, comorbidity (Charlson index 20 ) , and symptoms were based on independent physician assessment of the patients. Atrial fibrillation was diagnosed by ECG. All data obtained clinically and by functional tests were prospectively determined and collected in the study database as initially measured at time of surgery. The study was retrospective by design; follow-up, which was obtained from medical records, questionnaires, and contact with family and/or physician, was complete (last survey or death) in 1322 of the 1344 patients included in the study (98.4%) at 6.8Ϯ4.4 years.
Functional Tests
Preoperative echocardiographic examination was performed 25Ϯ32 days before surgery, and results were used as reported at examination. 21 LV diameters, left atrial diameter, and ejection fraction (EF) were measured. [22] [23] [24] LV quantitative angiography also was performed in 631 patients. Therefore, in adjustments for EF in the analysis of survival, the echocardiographic and angiographic EF measurements and their average value were used. Coronary angiography was performed in 1177 patients (88%), whereas in the remaining patients, lack of ischemic MR, angina, and history of myocardial infarction and younger age were considered consistent with very low probability of CAD. Overt CAD was considered present with significant stenosis (Ն70% in at least 1 vessel with or Ն50% in the left main).
Statistical Analysis
Results are presented as meanϮSD. Comparison between age groups used ANOVA for continuous variables or 2 test for categorical variables. Absolute survival (overall and "late" for operative survivors) was estimated with the Kaplan-Meier method, reported as Ϯ1 SE, and compared between groups by log-rank test. Multivariate analysis adjusted for other determinants of survival (sex, symptoms, EF, atrial fibrillation, creatinine, repair and coronary bypass performance, year of surgery) 8, 17, 23, 25 used Cox proportional hazards analysis, with age as the main determinant of interest expressed as categories (Ն75, 64 to 75, Ͻ65 years) or as a continuous variable. Comparison of observed with expected survival allowed us to measure relative survival (contrasted with that of age-and sexmatched 1990 US white population based on racial characteristics of the study population) and was tested univariately with the 1-sample log-rank test and in multivariate Cox proportional hazards analysis using an age-adjusted survival time variable 23 (dependent variable). Trends in operative mortality (within the first postoperative month or same hospitalization), low cardiac output (LCO; systolic blood pressure Ͻ90 mm Hg and cardiac index Ͻ1.4 L · min Ϫ1 · m Ϫ2 after surgery), length of hospital stay (log-transformed because of nonnormal distribution), and feasibility of valve repair were examined in 4 time periods (1980 -1983, 1984 -1987, 1988 -1991, 1992-1995) and tested with the Cochran-Armitage trend test and linear regression. Multivariate analyses of age category association to these end points used stepwise logistic regression. Analyses also were stratified by etiological groups (degenerative and nondegenerative MR). Entry in multivariate analyses required values of PϽ0. 15 , and values of PϽ0.05 were considered significant.
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Results

Baseline Characteristics
During the study period, 1344 patients (mean age, 65Ϯ12 years; 61% male) had mitral valve surgery for isolated MR. MR was degenerative in 856 (64%) and nondegenerative in 488 (36%) (functional/ischemic, 280; rheumatic, 86; endocarditis, 76; miscellaneous causes, 46). At surgery, 284 patients (21%) were Ն75 years of age, 504 (38%) were between 65 and 74 years of age, and 556 (41%) were Ͻ65 years of age. Preoperative characteristics by age group are listed in Table 1 . At presentation, patients Ն75 years of age displayed more severe characteristics with more advanced symptoms of heart failure, atrial fibrillation, comorbidity, CAD, ischemic MR, and need for combined bypass surgery (PϽ0.002 for all) compared with younger patients. No differences in preoperative LV systolic, LV diastolic, and left atrial size or in EF were found.
Long-Term Survival
Overall Survival
At the latest follow-up, 606 patients had died. Five-year survival stratified by age (Ն75, 65 to 74, Ͻ65 years) was 57Ϯ3%, 73Ϯ2%, and 85Ϯ2%, respectively (PϽ0.0001). In multivariate analysis, age Ն75 years was independently predictive of lower survival (risk ratio, 1.05 [95% confidence interval (CI), 1.04 to 1.06] per year of increasing age; PϽ0.001). However, when life expectancy was accounted for, 5-year overall relative survival stratified by age was similar (83%, 85%, and 88% of expected). In multivariate analysis of relative survival, age Ն75 compared with Ͻ65 years was not associated with long-term excess mortality (adjusted hazard ratio, 0.89; 95% CI, 0.73 to 1.30; Pϭ0.54), similar to age as a continuous variable (adjusted hazard ratio, 0.99 [95% CI, 0.98 to 1.01] per year of increasing age; Pϭ0.71).
Similarly, in degenerative MR, 5-year absolute survival stratified by age (Ն75, 65 to 74, Ͻ65 years) was 62%, 84%, and 93%, respectively (PϽ0.0001), but relative survival was similar at 91%, 98%, and 97%. In multivariate analysis of relative survival, age Ն75 compared with Ͻ65 years was not associated with excess mortality (adjusted hazard ratio, 1.3; 95% CI, 0.7 to 2.3; Pϭ0.39), similar to age as a continuous variable (adjusted hazard ratio, 1.01 [95% CI, 0.99 to 1.04] per year; Pϭ0.34). For nondegenerative MR, 5-year absolute survival stratified by age was lower at 46%, 56%, and 71%, respectively (PϽ0.0001), but relative survival was similar at 66%, 65%, and 74% of expected, respectively.
Late Survival
Five-year absolute late survival (in operative survivors) stratified by age (Ն75, 65 to 74, Ͻ65 years) was 64Ϯ3%, 79Ϯ2%, and 88Ϯ1%, respectively (PϽ0.0001). In multivar-iate analysis, age Ն75 years predicted lower absolute late survival, but 5-year late survival of patients Ն75 years of age was similar to their life expectancy (92.7% of expected; Pϭ0.15 versus expected) and was similar ( Figure 1A) to that of younger patients (92.6% and 92.6% for 65 to 74 and Ͻ65 years, respectively).
In degenerative MR, 5-year absolute late survival stratified by age (Ն75, 65 to 74, Ͻ65 years) was 69%, 86%, and 93%, respectively (PϽ0.0001), but relative late survival in patients Ն75 years of age matched the life expectancy (100% of expected; Pϭ0.69 versus expected) and was similar to that of younger (101% and 98% for 65 to 74 and Ͻ65 years, respectively; Figure 1B ). For nondegenerative MR, 5-year absolute late survival stratified by age was lower at 54%, 66%, 79% (PϽ0.001), representing similar fractions (77%, 74%, and 82%) of expected survival.
Perioperative Complications Trends
Operative Mortality Operative death trends over time ( , but the excess risk of operative mortality (odds ratio) associated with age Ն75 years decreased from the earliest to the latest period (Pϭ0.004). In degenerative MR also, operative mortality was higher in patients Ն75 versus Ͻ65 years of age (adjusted odd ratio, 5.4; 95% CI, 1.5 to 19.6; Pϭ0.01) despite the overall operative risk decline (Figure 2 , right). 
Postoperative Morbidity LCO trends over time (
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ratio, 2.8; 95% CI, 1.4 to 3.9; Pϭ0.003) despite LCO decline (Figure 3, right) . Ischemic strokes occurred in 25 patients within 30 days of surgery, and no significant difference was observed among age groups (1.3%, 2.6%, and 1.8% for patients Ͻ65, 65 to 74, and Ն75 years of age, respectively; Pϭ0.28). The difference remained insignificant when hemorrhagic strokes were included (Pϭ0.40).
Total hospital length-of-stay trends over time ( 
Valve Repair Trends
Throughout the study period, feasibility of mitral valve repair improved (overall from 30% in 1980 -1983 to 84% in 1992-1995; PϽ0.001; Table 2 ) similarly in patients Ն75, 65 to 74, and Ͻ65 years of age (PϽ0.001 for all; Figure 4 , left). Valve repair was as feasible in patients Ն75 years of age as in younger patients (Table 1) , and the association of valve repair with improved survival in patients Ն75 years of age was similar to that observed in younger patients (Pϭ0.21). Feasibility of repair improved in both degenerative and nondegenerative MR (PϽ0.001 for both; Table 2 ), but as demonstrated in Figure 4 (right), improvements in repair feasibility were considerable in degenerative MR, reaching 93% regardless of age in the most recent period.
Discussion
The present study shows that elderly patients undergoing mitral valve surgery for MR present with more severe baseline characteristics compared with younger patients. Long term after surgery, elderly patients incur higher mortality rates, but after age-specific expected mortality is accounted for, surgery results in similar restoration of life expectancy in all age groups and similar survival benefit after valve repair. The risk of surgery is higher in the elderly with higher operative mortality, higher incidence of LCO, and longer hospital stay, but over time, surgical improvements have resulted in considerable reduction in operative mortality and morbidity, particularly in the elderly population. Furthermore, remarkable increases in valve repair feasibility over time, similar for younger and older patients, resulted in a vast majority of patients undergoing this superior mode of surgical correction of MR. Despite the challenge presented by nondegenerative MR, which is associated with higher risk than degenerative MR, surgery should not be denied or unduly delayed on the basis of age alone and in the elderly can carefully be offered earlier, without waiting for severe or intractable heart failure.
Baseline Characteristics and Operative Risks
Cardiac surgery in the elderly is considered to carry high risks [3] [4] [5] and often is considered to be limited to patients with refractory heart failure. 12 However, MR is most prevalent in the elderly 2 and represents the second most common reason for valve surgery in this population. 26 Therefore, evaluating outcome in the elderly and temporal trends for improvement is essential for rational decisions about mitral surgery in the large population of elderly patients with MR.
Among baseline characteristics of elderly patients operated on for MR, age is only one of the unfavorable markers noted. Indeed, worse renal function and higher comorbidity scores are expected but underscore the risky presenta- tion of elderly patients with MR. 6, 14, 23 There also are cardiac risk factors noted in the elderly, particularly high CAD prevalence either incidental to or causing the MR. 27, 28 Regardless of these potential links to the MR mechanism, CAD has major consequences on outcome of MR surgery. 25, 29 Other cardiac risk factors associated with age are related to the management of patients with MR. Elderly patients are operated on for MR when most have developed severe symptoms and a large proportion have developed atrial fibrillation. Previous studies have demonstrated that despite postoperative improvement in symptoms, there is an adverse impact of preoperative severe symptoms on short-and long-term risk incurred after MR surgery. 8 Atrial fibrillation is directly associated with advanced age regardless of the presence of MR, 30 but it also is a direct consequence of MR, 31 which, when it becomes chronic, rarely reverts to sinus rhythm 32 and is associated with higher risk even after surgical correction of MR. 23 Hence, despite similar preoperative LV and atrial diameters in all age strata, reflecting a similar volume overload, and despite similar preoperative EF, elderly patients accumulate known risk factors for poor outcome of surgery. Whether age is, independently of these characteristics, 4 a direct marker of risk is of limited relevance, and our study shows that elderly patients incur higher operative mortality and morbidity with longer hospital stays than younger patients. 6,9 -11 However, beyond these relative risks, absolute risks incurred during surgery are Figure 2 . Trends in operative mortality throughout 4 periods covering the study duration (1980 -1983, 1984 -1987, 1988 -1991, 1992-1995) for patients Ն75 years of age (solid line), between 65 and 74 years of age (dotted line), and Ͻ65 years of age (dashed line) operated on for MR. Left, Trends in operative mortality for all causes of MR. Right, Trends in operative mortality for degenerative MR. The probability value applies to the time trends for all age group patients. (1980 -1983, 1984 -1987, 1988 -1991, 1992-1995) for patients Ն75 years of age (solid line), between 65 and 74 years of age (dotted line), and Ͻ65 years of age (dashed line) operated on for MR. Left, Trends in low output risk for all causes of MR. Right, Trends in low output risk for degenerative MR. The probability value applies to the time trends for all age group patients.
paramount to clinical decision making, emphasizing the importance of time trends.
Improvement Trends
From earliest to the most recent period of the present study, outstanding progress in operative care and surgical procedures has resulted in considerable improvement of perioperative outcomes with secular trends for decreased operative mortality, LCO incidence, and hospital stay, particularly in the elderly. Remarkably, the excess operative mortality risk in elderly patients decreased considerably throughout the study period, and because those results were obtained after adjustment for preoperative characteristics, they did not purely reflect improvements in patients' baseline characteristics. The decline in risks in the elderly is remarkable. Indeed, the last phase of the present study in the mid 1990s, designed to assess long-term outcome, shows that operative mortality in the elderly has declined considerably from 27% to 5%, but further improvements are expected. 33 Declines in morbidity (LCO) and length of hospital stay in the elderly also are remarkable. Another crucial improvement is the increase in valve repair. Valve repair is associated with improved operative and long-term survival over valve replacement 17, 34 and is now widely accepted as the preferred mode of correction of MR. [35] [36] [37] [38] In the present study, feasibility of repair improved considerably, reaching 93% for patients operated on for degenerative MR in the current era. Importantly, elderly patients, as compared with younger patients, saw similar gains in repair feasibility and benefited similarly from the valve repair for survival. 39 
Long-Term Outcome
Clinical Implications
In view of our results showing that despite higher operative risk, long-term outcome of MR surgery is good in the elderly, surgical correction of MR should not be denied on the basis of age alone but only on the basis of overwhelming comorbidity. National databases also suggest that current operative mortality for mitral valve repair is low, 40 but for individual patients, it is essential to estimate risk carefully on the basis of the results achieved by the surgical center and the patient's clinical presentation.
Valve repair is the preferred mode of correction of MR in the young population. Valve repair in the elderly is more disputed, 41 but our data show that it is equally feasible and provides as much survival benefit (compared with valve replacement) as valve repair in the younger population. Therefore, age, even advanced age, should not be considered as warranting valve replacement if valve repair is feasible.
In young patients in whom the risk of surgery is low, 23 an early repair strategy has been promoted as minimizing the long-term risks attached to MR. 42 Recent data on MR natural history have shown that with age, mortality and morbidity risks of MR under medical management increase markedly. [43] [44] [45] The concept of early surgery in the elderly has not been implemented because the operative mortality risks remained too high. The present study showing trends for considerable reduction in surgical risk should lead us to review the postponement rationale in the elderly with MR, in particular the concept that severe and/or refractory heart failure is a rational ground for MR surgery in the elderly. Notable challenges remain, related to nondegenerative MR, which is less reparable and involves higher risk, warranting a careful analysis of MR type and mechanism before surgical decisions are made. In addition, trends for higher repair rates are not specific to our institution and are noted nationally, but they are inhomogeneous and overall lower, so for specific patients, careful interpretation of the patient and institution characteristics is warranted. Despite this prudent approach, however, we believe that a safer surgery should carefully lead surgeons to consider prompt repair after diagnosis in patients with low comorbidity to obtain the best possible postoperative results. 8, 45 
Study Limitations
Elderly patients undergoing mitral surgery may not represent all elderly patients with MR, and the benefit of surgery cannot be defined without a randomized clinical trial, which is not yet available or even ongoing. Therefore, our conclusions apply only to the comparative risks and benefit of surgery in the young and elderly population. The similar relative postoperative survival in the young and elderly populations and the decreasing risks of surgery are encouraging factors in considering surgery in the elderly. (1980 -1983, 1984 -1987, 1988 -1991, 1992-1995) for patients Ն75 years of age (solid line), between 65 and 74 years of age (dotted line), and Ͻ65 years of age (dashed line) operated on for MR. Left, Trends in valve repair for all causes of MR. Right, Trends in valve repair for degenerative MR. The probability value applies to the time trends for all age group patients.
Conclusions
Elderly patients undergoing mitral valve surgery display more severe characteristics and incur higher operative risk. However, outstanding surgical improvements over time have resulted in a marked reduction in operative risks and considerable progress in repair feasibility and in similar restoration of life expectancy in older and younger patients. Therefore, in the present era, surgery should not be denied on the basis of age alone and, in carefully selected elderly patients, should be offered before the occurrence of refractory heart failure.
Source of Funding
Dr Detaint was supported by a grant from the French Federation of Cardiology.
Disclosures
Dr Enriquez-Sarano has participated in an advisory board for Edwards LLC; received honoraria from Edwards and Medtronic; and received research funding from Pfizer, AstraZeneca, and Edwards.
